columvi
roche registration gmbh - glofitamab - lymphoma, large b-cell, diffuse - antineoplastiski līdzekļi - columvi as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl), after two or more lines of systemic therapy.
talvey
janssen-cilag international n.v. - talquetamab - multiple mieloma - antineoplastiski līdzekļi - talvey is indicated as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least 3 prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti cd38 antibody and have demonstrated disease progression on the last therapy.
tepkinly
abbvie deutschland gmbh & co. kg - epcoritamab - lymphoma, large b-cell, diffuse - antineoplastiski līdzekļi - tepkinly as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large b-cell lymphoma (dlbcl) after two or more lines of systemic therapy.
herbitassin ® sūkājamas pastilas mutes dobumam ar medu un 20 augu ekstraktiem (2018.) pastila
domaco ag - pastila
halo gonseen (2017.) pulveris
dr. nona international ltd. - pulveris
korolen (paziņots) šķidrums
energy group a.s. - šķidrums
herbitassin® pastilas mutes dobumam ar augu ekstraktiem + medus (2019.) pastila
domaco dr.med aufdermaur ag - pastila
herbitassin® iceland moss + honey (2019.) pastila
domaco dr.med aufdermaur ag - pastila